Updating the approach to Crohn's disease

Stephen B. Hanauer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Recognizing clinical and pathologic scenarios, rather than ordering definitive tests, is still the basis for diagnosis of Crohn's disease. Steroids, salicylates, immunomodulating agents, and surgery remain the focus of treatment. The advent of infliximab, however, offers a new therapeutic option for patients with refractory disease.

Original languageEnglish (US)
Pages (from-to)77-94
Number of pages18
JournalHospital Practice
Volume34
Issue number8
DOIs
StatePublished - Aug 15 1999

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Updating the approach to Crohn's disease'. Together they form a unique fingerprint.

Cite this